SEC Form 4 · accession 0001209191-17-041047
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ron Cohen
Officer — President and CEO · Director
Period of report
Jun 16, 2017
Accepted (ET)
Jun 20, 2017 · 3:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 16, 2017 | P | 20,000 | $16.9499 | A | 511,648 | D | |
| Common StockF1 | holding | — | — | — | 42,940 | I | Beneficial Ownership in Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are held in a grantor retained annuity trust, which was established by the reporting person and of which he is the sole trustee.